Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Suzhou NeuPharma prepares novel bufalin derivatives

Aug. 5, 2011

FDA accepts ruxolitinib NDA filing for myelofibrosis

Aug. 4, 2011

Korean company prepares new AMPK activators

Aug. 4, 2011

Researchers at Sanofi present novel kinesin-like protein KIF11 inhibitors

Aug. 4, 2011

Novel protein Wnt signaling pathway inhibitors synthesized at Epitherix

Aug. 4, 2011

Lupeol curbs growth of androgen-dependent and castration-resistant prostate cancer cells

Aug. 4, 2011

EMA provides scientific advice regarding phase III trial of CPP-1X in FAP

Aug. 3, 2011

Encouraging interim results emerge from phase III study of Paclical

Aug. 3, 2011

Bionomics provides update on clinical trials of anticancer candidate BNC-105

Aug. 3, 2011

OncoTherapy Science's anticancer vaccine OTS-102 obtains generic name

Aug. 3, 2011

Popular Stories

Today's news in brief
BioWorld
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...